// Company Overview //
| Stock Name | 希瑪眼科醫療控股有限公司 |
| Stock Code | 03309 |
| Company Full Name | 希瑪眼科醫療控股有限公司 |
| Industry | 醫療保健 |
| Principal Activities | 主要於香港及中國內地提供眼科服務,及銷售視力輔助產品及醫藥產品。 |
| Listing Date | 2018-01-15 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | No data |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 香港畢打街1-3號中建大廈1535室 |
| Business Address (Hong Kong) | No data |
| Place of Incorporation | No data |
| Listing Method | No data |
| Listing Board | Main Board |
| Website | http://www.cmermedical.com |
| Share Registrar | 香港中央證券登記有限公司 |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
// Offering Information //
| Prospectus Date | 2017-12-29 |
| Offer Price | HK$ 2.90 / shares |
| Total Funds Raised | HK$ 285,650,000 |
// Valuation & Financials //
| Market Cap (at Offer Price) | HK$ 0 |
// First Day Performance
| First Day Close | Loading... |
| First Day Open | HK$ 5.35 |
| First Day Change | 76.21% |
| First Day Volume | 211598000.0 |
| First Day Turnover | 1120740000.0 |
// Price Chart //
// Use of Proceeds
| Use of Proceeds | 1、221.6百萬港元(或42.5%)用于對選定中國城市三間運營中眼科醫院的潛在收購;
2、210.6百萬港元(或40.4%)用于在選定的中國城市開設三間眼科醫院;
3、21.9百萬港元(或4.2%)用于在中國深圳開設兩間衛星診所;
4、44.3百萬港元(或8.5%)用于升級我們的醫療設備及強化我們在香港及中國的信息科技系統;
5、22.9百萬港元(或4.4%)用于我們的營運資金及一般企業用途。 |
// Underwriting Syndicate //
// Cornerstone Investors //
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
| 1 |
Advance Data Services Limited |
68,805,400 HKD |
— |
12.00% |
— |
6 months |
2018-07-15 |
| 2 |
Gunther Group Limited |
68,805,400 HKD |
— |
12.00% |
— |
6 months |
2018-07-15 |
| 3 |
香港华丽有限公司 |
68,805,400 HKD |
— |
12.00% |
— |
6 months |
2018-07-15 |
// Directors & Management //
| Chairman | 林順潮 |
| Company Secretary | 陳華平 |
No director data available.
// Major Shareholders //
| Major Shareholders & Holdings | 林順潮及家族成員(54.41%) |
Disclaimer & Risk Warning
Site Nature: This website (cibo.qizai.ai) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.
Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. Some data is supplemented from HKEX New Listing Reports ([HKEX]). All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.
Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.
Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.
Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.